After the rise of affordable knock-offs, the ultra-rich then moved the goalpost to a new standard of wealth: health and aesthetic beauty.

Novo Nordisk drops Hims & Hers because it was selling and promoting a cheaper copycat of Wegovy, its weight loss drug.

Live news, investigations, opinion, photos and video by the journalists of The New York Times from more than 150 countries around the world. Subscribe for coverage of U.S. and international news ...

The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and deaths.

Parenting Ozempic use among teens is skyrocketing — and parents are getting a stern warning from experts By Marissa Matozzo Published June 12, 2025, 4:00 p.m. ET ...

We ask people in Birmingham whether they’d ever buy a convincing fake if it meant saving money. Is it ever worth the risk—and how can you tell what you’re buying online is genuine?

Some medical experts warn that as Ozempic helps overcome food addiction, the junk food industry is adapting with ultraprocessed foods designed to hijack brain reward systems.

Novo Nordisk, the Danish pharma company behind Ozempic, made a very dumb decision a few years ago that will massively eat into its profits.

A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions.

Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap knock-offs of the weight loss drug Wegovy, it said on Monday.

Could YOU make a pile of cash investing in the never-ending craze for Mounjaro and Ozempic? Anne Ashworth reveals what you need to know on Eli Lilly and Novo Nordisk ...

Experts discuss how weight loss can trigger temporary hair loss, with hairstylists and an endocrinologist providing insights on managing symptoms and hair regrowth.